Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mekanistic Therapeutics

Request full access

Dual EGFR and PI3K precision oncology inhibitors

Minneapolis, United StatesFounded 2022Biotech & Life Sciences

About Mekanistic Therapeutics

Mekanistic Therapeutics is a precision oncology company developing single-molecule kinase inhibitors designed to hit multiple cancer pathways at once and reduce resistance and combination-therapy complexity. Its lead candidate MTX-531 is a first-in-class dual EGFR and PI3K inhibitor intended to deliver coordinated pathway blockade with a simpler dosing profile than two-drug regimens.

The company is a University of Michigan spin-out led by kinase and computational chemistry experts, advancing MTX-531 through IND-enabling work and clinical preparation for resistant solid tumors such as head and neck cancers, with broader oncology potential. Preclinical results and NCI partnership support the dual-inhibition approach, including efforts to limit hyperglycemia toxicity seen with some PI3K agents.

Business model is biotech drug discovery and development for targeted cancer therapy. Official website mekanistic.com and LinkedIn mekanistic-therapeutics brand Mekanistic Therapeutics for dual EGFR/PI3K oncology assets.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
78.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, Woman Founder, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Jun 2022 $30M $120M Undisclosed ↗
SPINOUT✓Other financing Jan 2022 $0 — University of Michigan —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Mekanistic Therapeutics website traffic

Latest recorded traffic for Mekanistic Therapeutics is 630 monthly website visits, up 6200% over the last three months. Mekanistic Therapeutics's team grew 14.3% over the past year.

Latest monthly visits630 3-month web change+6200% 1-year team growth+14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Mekanistic Therapeutics in the Minneapolis ecosystem

Live from Dealroom

The Mekanistic Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • University of Michigan
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mekanistic Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mekanistic Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.